News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Esketamine monotherapy shows robust, rapid efficacy as treatment for TRD
17 Jul 2025
byMike Ng
Intranasal esketamine, administered at two fixed doses as monotherapy for treatment-resistant depression (TRD), has demonstrated robust and rapid efficacy in a phase IV double-blind, placebo-controlled randomized trial.
Esketamine monotherapy shows robust, rapid efficacy as treatment for TRD
17 Jul 2025
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
byMike Ng
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.







